Published in Cancer Epidemiol on April 05, 2011
Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56
The role of chronic inflammation in obesity-associated cancers. ISRN Oncol (2013) 1.04
Metabolic syndrome as a risk factor for Barrett esophagus: a population-based case-control study. Mayo Clin Proc (2013) 0.99
Slug is a predictor of poor prognosis in esophageal squamous cell carcinoma patients. PLoS One (2013) 0.90
The association between obesity factor and esophageal caner. J Gastrointest Oncol (2012) 0.90
Emerging optical methods for surveillance of Barrett's oesophagus. Gut (2015) 0.88
Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis (2014) 0.87
Metabolic syndrome increases risk of Barrett esophagus in the absence of gastroesophageal reflux: an analysis of SEER-Medicare Data. J Clin Gastroenterol (2015) 0.86
The effect of abdominal visceral fat, circulating inflammatory cytokines, and leptin levels on reflux esophagitis. J Neurogastroenterol Motil (2015) 0.84
Obesity and future prostate cancer risk among men after an initial benign biopsy of the prostate. Cancer Epidemiol Biomarkers Prev (2013) 0.83
Metabolic syndrome, obesity, and gastrointestinal cancer. Gastroenterol Res Pract (2012) 0.82
Research advances in esophageal diseases: bench to bedside. F1000Prime Rep (2013) 0.82
Childhood body mass index in relation to future risk of oesophageal adenocarcinoma. Br J Cancer (2015) 0.81
The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas. Int J Surg Oncol (2013) 0.81
Current pharmacological management of gastroesophageal reflux disease. Gastroenterol Res Pract (2013) 0.80
Age-specific risk factor profiles of adenocarcinomas of the esophagus: A pooled analysis from the international BEACON consortium. Int J Cancer (2015) 0.79
Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterol Clin North Am (2015) 0.79
Insulin/Insulin-Like Growth Factor-1 Pathway in Barrett's Carcinogenesis. Clin Transl Gastroenterol (2013) 0.78
Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis. BMC Cancer (2014) 0.78
Considerations for Defining Cytokine Dose, Duration, and Milieu That Are Appropriate for Modeling Chronic Low-Grade Inflammation in Type 2 Diabetes. J Diabetes Res (2016) 0.77
Gastrointestinal morbidity in obesity. Ann N Y Acad Sci (2014) 0.77
The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death. Oncotarget (2016) 0.77
Managing gastroesophageal reflux disease in children: The role of endoscopy. World J Gastrointest Endosc (2012) 0.76
An age-period-cohort analysis of obesity and incident esophageal adenocarcinoma among white males. Dis Esophagus (2016) 0.76
Adipose tissue-secreted miR-27a promotes liver cancer by targeting FOXO1 in obese individuals. Onco Targets Ther (2015) 0.75
Metabolic syndrome is associated with increased risk of Barrett esophagus: A meta-analysis. Medicine (Baltimore) (2016) 0.75
Is Metabolic Syndrome Considered to Be a Risk Factor for Gastroesophageal Reflux Disease (Non-Erosive or Erosive Esophagitis)?: A Systematic Review of the Evidence. Iran Red Crescent Med J (2016) 0.75
Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies. Br J Cancer (2017) 0.75
The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials. BBA Clin (2015) 0.75
The Neurobiological Impact of Ghrelin Suppression after Oesophagectomy. Int J Mol Sci (2016) 0.75
Plant Lectins as Medical Tools against Digestive System Cancers. Int J Mol Sci (2017) 0.75
Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75
Enteral nutrition enriched with eicosapentaenoic acid (EPA) preserves lean body mass following esophageal cancer surgery: results of a double-blinded randomized controlled trial. Ann Surg (2009) 2.64
International Consensus on Standardization of Data Collection for Complications Associated With Esophagectomy: Esophagectomy Complications Consensus Group (ECCG). Ann Surg (2015) 2.61
Barrett esophagus: prevalence of central adiposity, metabolic syndrome, and a proinflammatory state. Ann Surg (2008) 2.30
The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc (2008) 2.21
Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol (2007) 1.96
IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol (2011) 1.72
Lipoxygenase metabolism: roles in tumor progression and survival. Cancer Metastasis Rev (2007) 1.57
Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative. Arch Ophthalmol (2006) 1.55
Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol (2012) 1.54
Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52
Cancer cachexia: mechanisms and clinical implications. Gastroenterol Res Pract (2011) 1.45
Hiccups as the only symptom of non-ST-segment elevation myocardial infarction. Am J Emerg Med (2011) 1.44
Consumption of sugary foods and drinks and risk of endometrial cancer. Cancer Causes Control (2013) 1.38
Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res (2006) 1.32
NF-kappaB activation in esophageal adenocarcinoma: relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann Surg (2004) 1.31
Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr (2011) 1.26
The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Gastroenterology (2008) 1.25
Comparison of transesophageal endoscopic plication (TEP) with laparoscopic Nissen fundoplication (LNF) in the treatment of uncomplicated reflux disease. Am J Gastroenterol (2006) 1.23
Associations between age-related nuclear cataract and lutein and zeaxanthin in the diet and serum in the Carotenoids in the Age-Related Eye Disease Study, an Ancillary Study of the Women's Health Initiative. Arch Ophthalmol (2008) 1.19
Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol (2009) 1.17
MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J Mol Med (Berl) (2012) 1.16
Prediction of nephrotoxicant action and identification of candidate toxicity-related biomarkers. Toxicol Pathol (2005) 1.15
Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc (2011) 1.14
Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol (2011) 1.13
Gene expression analysis of diagnostic biopsies predicts pathological response to neoadjuvant chemoradiotherapy of esophageal cancer. Ann Surg (2009) 1.09
Multicenter Evaluation of Rectal cancer ReImaging POst Neoadjuvant (MERRION) Therapy. Ann Surg (2015) 1.08
Impact of obesity on outcomes in the management of localized adenocarcinoma of the esophagus and esophagogastric junction. J Thorac Cardiovasc Surg (2007) 1.07
Upper gastrointestinal bleeding: predictors of risk in a mixed patient group including variceal and nonvariceal haemorrhage. Eur J Gastroenterol Hepatol (2012) 1.04
Post-oesophagectomy early enteral nutrition via a needle catheter jejunostomy: 8-year experience at a specialist unit. Clin Nutr (2006) 1.02
Association of hypoalbuminemia on the first postoperative day and complications following esophagectomy. J Gastrointest Surg (2007) 1.02
Impact of obesity on surgical and oncological outcomes in the management of colorectal cancer. Int J Colorectal Dis (2010) 1.01
Obesity, orbitofrontal structure and function are associated with food choice: a cross-sectional study. BMJ Open (2011) 1.01
Concordance with World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) guidelines for cancer prevention and obesity-related cancer risk in the Framingham Offspring cohort (1991-2008). Cancer Causes Control (2015) 0.97
Barrett's to oesophageal cancer sequence: a model of inflammatory-driven upper gastrointestinal cancer. Dig Surg (2012) 0.97
A population-based association study of SNPs of GSTP1, MnSOD, GPX2 and Barrett's esophagus and esophageal adenocarcinoma. Carcinogenesis (2007) 0.96
No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study. Cancer Epidemiol Biomarkers Prev (2008) 0.95
COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemotherapy. Int J Radiat Oncol Biol Phys (2005) 0.95
Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett's esophagus. J Nutr (2010) 0.95
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Invest New Drugs (2010) 0.95
Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surg (2004) 0.94
Low pH induces co-ordinate regulation of gene expression in oesophageal cells. Carcinogenesis (2005) 0.94
Short-term nutritional implications of total gastrectomy for malignancy, and the impact of parenteral nutritional support. Clin Nutr (2007) 0.94
Nanodrug applications in photodynamic therapy. Photodiagnosis Photodyn Ther (2010) 0.94
Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity. Eur J Cancer (2006) 0.94
Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Cancer Causes Control (2008) 0.93
Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma. Radiat Res (2010) 0.93
Germline polymorphisms in genes involved in the CD44 signaling pathway are associated with clinical outcome in localized gastric adenocarcinoma. Int J Cancer (2011) 0.92
COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Biochim Biophys Acta (2011) 0.91
Defining a successful esophagectomy. Ann Surg (2014) 0.91
Extracellular ATP mediates the late phase of neutrophil recruitment to the lung in murine models of acute lung injury. Am J Physiol Lung Cell Mol Physiol (2013) 0.91
Suspected nonalcoholic Fatty liver disease is not associated with vitamin d status in adolescents after adjustment for obesity. J Obes (2011) 0.90
Combination of SELDI-TOF-MS and data mining provides early-stage response prediction for rectal tumors undergoing multimodal neoadjuvant therapy. Ann Surg (2007) 0.90
Short bowel syndrome. Surgeon (2010) 0.90
MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation. Mol Carcinog (2011) 0.89
Radiation sensitivity of esophageal adenocarcinoma: the contribution of the RNA-binding protein RNPC1 and p21-mediated cell cycle arrest to radioresistance. Radiat Res (2012) 0.89
The role of prostacyclin synthase and thromboxane synthase signaling in the development and progression of cancer. Biochim Biophys Acta (2010) 0.88
Cyclooxygenase-2 and inducible nitric oxide synthase gene polymorphisms and risk of reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2008) 0.88
Cellular origins and molecular mechanisms of Barrett's esophagus and esophageal adenocarcinoma. Ann N Y Acad Sci (2013) 0.88
Helicobacter pylori extract induces nuclear factor-kappa B, activator protein-1, and cyclooxygenase-2 in esophageal epithelial cells. J Gastrointest Surg (2006) 0.87
Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women. Cancer Causes Control (2012) 0.87
Gastric neuroendocrine tumours. Dig Surg (2012) 0.87
Dietary fat in breast cancer survival. Annu Rev Nutr (2013) 0.86
Can CT-PET and Endoscopic Assessment Post-Neoadjuvant Chemoradiotherapy Predict Residual Disease in Esophageal Cancer? Ann Surg (2016) 0.86
Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus. Ann N Y Acad Sci (2013) 0.86
Long-term health-related quality of life for disease-free esophageal cancer patients. World J Surg (2011) 0.86
Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr Res (2013) 0.85
Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib. Am J Clin Oncol (2017) 0.85
Potential role of NF-kappaB in esophageal adenocarcinoma: as an emerging molecular target. J Surg Res (2008) 0.85
New-onset mediastinal and central nervous system sarcoidosis in a patient with metastatic melanoma undergoing CTLA4 monoclonal antibody treatment. Oncol Res Treat (2014) 0.85
Serum proteomic profiling reveals that pretreatment complement protein levels are predictive of esophageal cancer patient response to neoadjuvant chemoradiation. Ann Surg (2011) 0.84
Impact of solitary involved lymph node on outcome in localized cancer of the esophagus and esophagogastric junction. J Gastrointest Surg (2007) 0.84
Treatment options for esophageal cancer. Expert Opin Pharmacother (2008) 0.84
Evidence-based selective application of transhiatal esophagectomy in a high-volume esophageal center. World J Surg (2012) 0.84
Appraisal of staging endoscopic ultrasonography in a modern high-volume esophageal program. World J Surg (2013) 0.83
Perioperative evaluation of the obese patient. J Clin Anesth (2011) 0.83
Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus. J Nucl Med (2010) 0.83
Associations between dietary variety and measures of body adiposity: a systematic review of epidemiological studies. Br J Nutr (2013) 0.83
Eosinophilic ascites with marked peripheral eosinophilia: a diagnostic challenge. Eur J Gastroenterol Hepatol (2014) 0.83
Sorafenib-induced tuberculosis reactivation. Onkologie (2012) 0.82
Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Ann Surg (2007) 0.82
Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer. Mol Carcinog (2011) 0.82
Elevated Tumor Expression of PAI-1 and SNAI2 in Obese Esophageal Adenocarcinoma Patients and Impact on Prognosis. Clin Transl Gastroenterol (2012) 0.82
(18)F-FDG PET-detected synchronous primary neoplasms in the staging of esophageal cancer: incidence, cost, and impact on management. Clin Nucl Med (2012) 0.82
Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard. Ann Surg (2013) 0.82
Testicular cancer and platinum: a double-edged sword. J Clin Oncol (2014) 0.82
Acid normalization and improved esophageal motility after Nissen fundoplication: equivalent outcomes in patients with normal and ineffective esophageal motility. Am J Surg (2005) 0.82
Inhibition of pro-inflammatory cytokine generation by CTLA4-Ig in the skin and colon of mice adoptively transplanted with CD45RBhi CD4+ T cells correlates with suppression of psoriasis and colitis. Int Immunopharmacol (2002) 0.81
Greater healthful food variety as measured by the US Healthy Food Diversity index is associated with lower odds of metabolic syndrome and its components in US adults. J Nutr (2014) 0.81
Necrotizing pancreatitis presenting with pneumatosis coli and hepatic portal venous gas. ANZ J Surg (2011) 0.80
Racial differences in the association of insulin-like growth factor pathway and colorectal adenoma risk. Cancer Causes Control (2013) 0.80
Treatment of BRAF inhibitor-induced hyperkeratosis. Acta Oncol (2012) 0.80
Application of genomics for identification of systemic toxicity triggers associated with VEGF-R inhibitors. Chem Res Toxicol (2010) 0.79
The SGBS cell strain as a model for the in vitro study of obesity and cancer. Clin Transl Oncol (2012) 0.79
Fast-track protocols in colorectal surgery. Surgeon (2011) 0.79
Post irradiation olfactory neuroblastoma (esthesioneuroblastoma): a case report and up to date review. Acta Oncol (2009) 0.79